votes of the shareholders who attend the meeting and have the right to vote. 4. Details of Assets Acquired: The Company will purchase 100% of the ordinary shares of Modern Pharma Company Limited. The
= NTA of investment in the Company x The acquired proportion x 100 NTA of the Company 6.59% 2. Net Profit from Core business after tax = Net profit from the acquiring assets x 100 Total net profit of the
subsidiary acquired new fixed assets amounting to 135.46 million baht in which derived from purchase of land and factory building from related person for the subsidiary’s lease for operation amounting to 60.34
to be paid / Total Asset of ORI) x 100 4. Value of Securities issued by the Company as consideration for the assets acquired = No. of shares issued in consideration of the assets x 100 / No. of issued
Concerning the Connected Transactions B.E. 2546. 3. General Characteristic of the Transactions and Details of the Acquired Assets 3.1 General Characteristic of the Transaction The Subsidiary shall purchase
Sign Co. Ltd., (“Multi Sign”) and COMASS Co. Ltd., (“COMASS”) which was acquired in October 2016 and July 2017, respectively. The consolidation has expanded MACO’s nationwide footprints and increased
profit margin in the third quarter of 2017 was 57.2%. This gross margin had accounted for the fair value adjustment of the acquired business according to the accounting standards under WHA level. However
asset value of the ORI) x 100 4. Value of Securities issued by the Company as consideration for the assets acquired = No. of shares issued in consideration of the assets x 100 / No. of issued and paid-up
in the third quarter of 2017 was 56.6%. This gross margin had accounted for the fair value adjustment of the acquired business according to the accounting standards under WHA level. However, the